Medical Weight Loss for Santa Maria, California Residents

Santa Maria, California residents get physician-supervised weight loss by telehealth from New Hope Weight Loss: a $119 doctor review, then compounded semaglutide from $166/month or tirzepatide from $233/month.

Physician-supervised GLP-1 programs from $166/month, serving Santa Maria through telehealth from our Costa Mesa, California clinic. Doctor review $119. Over 5,400 patients treated.

Same physician, wherever you live in California: patients in Santa Maria see the same Dr. Sharma and the same protocol as our Costa Mesa, California patients, just delivered by telehealth instead of in person. Results vary. Doctor review just $119 (medication separate).

Why Santa Maria Residents Choose New Hope Weight Loss

You never have to leave Santa Maria to work with us. The entire program runs by telehealth from our clinic in Costa Mesa, California, so your consultation, your follow-ups, and your dose adjustments all happen by video and message from wherever you are in California. Whether you live near downtown Santa Maria and the northern Santa Barbara County coast or further out, the care is identical. No commute, no waiting room, no rearranging your week around an appointment across town.

From our Costa Mesa, California practice, we provide Santa Maria with physician-supervised GLP-1 care entirely by telehealth. Treatment is prescribed only after Dr. Sharma's review, and medication ships discreetly to your door.

Telehealth is what lets us care for Santa Maria, California from a single office in Costa Mesa, so you get Dr. Sharma's full attention without rearranging your day around an appointment across town. We care for patients throughout downtown Santa Maria and the northern Santa Barbara County coast. Semaglutide starts from $166 a month, or $499 for the 90-day program, and tirzepatide from $233 a month, the same pricing for every California patient.

Because your care happens by telehealth, there is no waitlist to clear and most Santa Maria patients can have their physician visit scheduled within the same week. Because every Santa Maria visit happens by video, there is no local office to drive to and no travel cost added to your $119 review. California is our home state and our physical clinic sits in Costa Mesa, but we care for patients across the rest of the state by secure telehealth.

GLP-1 Weight Loss Programs Available

Which GLP-1 program is right for you?

Our 90-Day Metabolic Reset runs on semaglutide, the same active ingredient as Wegovy and Ozempic. It starts at $166 a month, or $499 for 90 days, and branded-drug trials reported average loss near 15 to 17 percent. Because compounded semaglutide is not FDA-approved or brand-identical, results vary. Dr. Sharma guides every Santa Maria patient by telehealth.

And if you want more horsepower

Tirzepatide, from $233 a month, adds GIP to the usual GLP-1 action. In branded-drug trials, dose-qualified participants reached up to 22.5 percent loss, which is not the typical outcome. It shares its active ingredient with Mounjaro and Zepbound.

A $119 physician review starts the process. Medication billed separately. HSA, FSA, Klarna, and Affirm accepted.

How Telehealth Works for Santa Maria

Step 1: The quiz. Tell us about your health history, current weight, and goals through a quick online intake.

Step 2: The video visit. Dr. Sharma reviews your intake and meets you by secure video, usually within 48 hours, to discuss whether compounded semaglutide or tirzepatide is a fit. Results vary from person to person.

Step 3: Delivery. A state-licensed 503(a) pharmacy ships your medication to your Santa Maria address in cold-pack packaging.

Step 4: Follow-ups. You stay in touch by video as you progress.

Frequently Asked Questions, Santa Maria

Where is the closest New Hope Weight Loss to Santa Maria?

Our clinic is physically located in Costa Mesa, California, and it is the only one we operate. Distance is not a barrier, though, because Santa Maria, California patients are cared for through telehealth. During a video consultation, Dr. Anjmun Sharma reviews your situation and confirms your eligibility for a compounded GLP-1 plan.

Is in-person attendance required for patients from Santa Maria?

It is not. We run a complete telehealth model, so people in Santa Maria handle everything from home. Your appointment with Dr. Sharma, your paperwork, and your follow-ups are all online. Approved medication is shipped to Santa Maria using cold-pack insulation that keeps it stable until it reaches you.

What should a Santa Maria patient budget for care?

The visit with the physician is $119. Semaglutide starts at $166 monthly or $499 for the 90-day program, and tirzepatide at $233 monthly. The drug is billed apart from the consult. We take HSA, FSA, Klarna, and Affirm, and Santa Maria patients are not charged any extra distance fee.

What areas of Santa Maria do you serve?

We serve patients from across Santa Maria by telehealth, including downtown Santa Maria and the northern Santa Barbara County coast.

How does telehealth treatment work for Santa Maria patients?

You complete the online medical intake, Dr. Sharma reviews your history by secure video, typically within 48 hours, and if you are a candidate and telehealth-eligible, compounded medication ships to your Santa Maria address. Follow-ups also happen by video.

Santa Maria Residents, Get Started Today

Doctor review $119. Semaglutide from $166/mo. Tirzepatide from $233/mo. Medication separate.

Start My Journey →

New Hope Weight Loss | clinic at 1503 South Coast Drive, Suite 322, Costa Mesa, CA 92626 | (657) 837-3342 | Serving Santa Maria, California by telehealth. Telehealth availability and eligibility are confirmed during the medical consultation.

Wegovy® and Ozempic® are registered trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are registered trademarks of Eli Lilly and Company. New Hope Weight Loss is not affiliated with or endorsed by these companies. Compounded semaglutide and tirzepatide are prepared by licensed U.S. pharmacies and are not FDA-approved, not brand-identical, and not reviewed by the FDA for safety, effectiveness, or quality.